Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 20:14:55.
doi: 10.3389/fncel.2020.00055. eCollection 2020.

Effects of Ginseng on Neurological Disorders

Affiliations
Review

Effects of Ginseng on Neurological Disorders

Wei Hou et al. Front Cell Neurosci. .

Abstract

Ginseng (Panax ginseng Meyer), a famous traditional medicinal herb, has been widely used for many centuries. Numerous studies have shown that ginseng has a positive effect on the prevention and treatment of neurological disorders. In this review, we summarized the effects of ginseng in treating neurological diseases, particularly the anti-depressant effects of ginseng. Furthermore, its potential mechanism was also outlined. Therefore, this review may provide new insight into the treatment of ginseng on neurological diseases.

Keywords: BDNF; depression; ginseng; neurological disorder; neuron.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram summarizing the antidepressant effect of ginseng via the BDNF-TrkB signal path. G115, ginseng extract G115; BDNF, brain-derived neurotrophic factor; VEGF, vascular endothelial growth factor; PI3K, phosphoinositide 3-kinase; AKT, protein kinase B; mTOR, mammalian target of rapamycin; MAPK, mitogen-activated protein kinase; ERK, extracellular regulated protein kinases; CREB, cAMP-response element-binding protein.
Figure 2
Figure 2
Schematic diagram summarizing the antidepressant effect of ginseng via the HPA axis. CRH, corticotrophin-releasing hormone; AV, arginine vasopressin; ACTH, adrenocorticotropic hormone; CRF, corticotropin-releasing factor; GR, glucocorticoid receptor; AR, androgen receptor; GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; DS, dammarane sapogenins; PGE, Panax ginseng extract; GTS, ginseng total saponins.
Figure 3
Figure 3
Schematic diagram summarizing the potential protective effects of ginseng and its constituents against neurodegeneration. Aβ, amyloid beta peptide; TLRs, toll-like receptors; AD, Alzheimer's disease; HD, Huntington's disease; PD, Parkinson's disease; NF-κB, nuclear factor-kappa-light-chain-enhancer of an activated B cell; JNK, c-Jun N-terminal kinase, AChE, acetylcholinesterase; ERK, extracellular signal-regulated kinase; RG, red ginseng.

References

    1. Albert P. R., Benkelfat C., Descarries L. (2012). The neurobiology of depression–revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 2378–2381. 10.1098/rstb.2012.0190 - DOI - PMC - PubMed
    1. Aleksandrova L. R., Wang Y. T., Phillips A. G. (2019). Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response. Neurosci. Biobehav. Rev. 105, 1–23. 10.1016/j.neubiorev.2019.07.007 - DOI - PubMed
    1. Arborelius L., Owens M. J., Plotsky P. M., Nemeroff C. B. (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160, 1–12. 10.1677/joe.0.1600001 - DOI - PubMed
    1. Bertrand P. P., Bertrand R. L. (2010). Serotonin release and uptake in the gastrointestinal tract. Auton. Neurosci. 153, 47–57. 10.1016/j.autneu.2009.08.002 - DOI - PubMed
    1. Bocchio-Chiavetto L., Bagnardi V., Zanardini R., Molteni R., Nielsen M. G., Placentino A., et al. . (2010). Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J. Biol. Psychiatry 11, 763–773. 10.3109/15622971003611319 - DOI - PubMed

LinkOut - more resources